Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
34.31 USD | -0.49% | -3.11% | -6.92% |
Bewertung
Steuerjahr: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Marktwert 1 | 775.4 | 3’393 | 5’273 | 1’986 | 1’163 | 1’994 | - | - |
Unternehmenswert 1 | 645 | 3’108 | 4’808 | 1’608 | 876.4 | 1’820 | 1’854 | 1’875 |
KGV | -6.09 x | -21.3 x | -34 x | -8.72 x | -5.63 x | -11.2 x | -12.8 x | -14.6 x |
Rendite | - | - | - | - | - | - | - | - |
Marktkapitalisierung / Umsatz | 14.3 x | 37.7 x | 39.8 x | 9.76 x | 4.74 x | 6.8 x | 5.59 x | 4.71 x |
Unternehmenswert / Umsatz | 11.9 x | 34.5 x | 36.3 x | 7.9 x | 3.58 x | 6.21 x | 5.2 x | 4.43 x |
Unternehmenswert / EBITDA | -6.28 x | -28 x | -33.5 x | -7.37 x | -4.67 x | -12 x | -13.9 x | -152 x |
Unternehmenswert / FCF | -6.28 x | -20.4 x | -34.5 x | -7.11 x | -5.15 x | -17.3 x | -19.9 x | -25.4 x |
FCF Yield | -15.9% | -4.89% | -2.9% | -14.1% | -19.4% | -5.79% | -5.04% | -3.94% |
Price to Book | 4.3 x | 10.2 x | 9.12 x | 2.52 x | 1.87 x | 3.9 x | 4.51 x | 5.61 x |
Anz. der Aktien (in Tausend) | 32’472 | 44’663 | 49’292 | 56’364 | 57’396 | 57’818 | - | - |
Referenzkurs 2 | 23.88 | 75.97 | 107.0 | 35.24 | 20.26 | 34.31 | 34.31 | 34.31 |
Datum der Veröffentlichung | 11.12.19 | 23.11.20 | 22.11.21 | 18.11.22 | 17.11.23 | - | - | - |
Ergebnisentwicklung (Jahreszahlen)
Steuerjahr: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Umsatz 1 | 54.38 | 90.1 | 132.3 | 203.6 | 245.1 | 293.1 | 356.3 | 423.5 |
EBITDA 1 | -102.7 | -110.9 | -143.5 | -218.3 | -187.8 | -151.5 | -133.1 | -12.34 |
Betriebsergebnis (EBIT) 1 | -108.8 | -117.6 | -153.3 | -234.8 | -217.2 | -188.3 | -160.4 | -116.2 |
Umsatzrendite | -200.15% | -130.5% | -115.81% | -115.33% | -88.6% | -64.23% | -45.02% | -27.45% |
Gewinn vor Steuern (EBT) 1 | -107.4 | -139.5 | -154 | -228.3 | -203.5 | -178.6 | -156.8 | -108.3 |
Nettoergebnis 1 | -107.7 | -139.9 | -152.1 | -217.9 | -204.6 | -180.3 | -155.8 | -109.3 |
Nettomarge | -197.98% | -155.31% | -114.94% | -107.02% | -83.48% | -61.51% | -43.71% | -25.81% |
Gewinn pro Aktie 2 | -3.920 | -3.570 | -3.150 | -4.040 | -3.600 | -3.066 | -2.679 | -2.357 |
Free Cash Flow 1 | -102.7 | -152.1 | -139.3 | -226.2 | -170.3 | -105.3 | -93.38 | -73.89 |
FCF-Marge N | -188.83% | -168.84% | -105.27% | -111.14% | -69.46% | -35.93% | -26.21% | -17.45% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Nettoergebnis) | - | - | - | - | - | - | - | - |
Dividende pro Aktie | - | - | - | - | - | - | - | - |
Datum der Veröffentlichung | 11.12.19 | 23.11.20 | 22.11.21 | 18.11.22 | 17.11.23 | - | - | - |
Ergebnisentwicklung (Quartalszahlen)
Steuerjahr: September | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz 1 | 37.95 | 42.02 | 48.13 | 56.11 | 57.31 | 54.24 | 60.18 | 63.74 | 66.95 | 71.5 | 70.77 | 73.92 | 77.34 | 83.46 | 83.62 |
EBITDA 1 | -39.8 | -55.62 | -56.83 | -56.72 | - | -43.47 | - | -52.29 | -41.61 | -38.81 | -39.4 | -38.2 | -36.65 | - | - |
Betriebsergebnis (EBIT) 1 | -42.23 | -58.77 | -60.8 | -61.16 | -56.87 | -48.76 | -62.83 | -60.78 | -50.11 | -46.98 | -49.57 | -47.06 | -43.66 | -38.07 | -43.26 |
Umsatzrendite | -111.28% | -139.86% | -126.34% | -109% | -99.24% | -89.9% | -104.41% | -95.36% | -74.85% | -65.7% | -70.04% | -63.67% | -56.45% | -45.62% | -51.74% |
Gewinn vor Steuern (EBT) 1 | -40.9 | -55.97 | -60.82 | -60.67 | -50.82 | -41.75 | -58.48 | -56.77 | -46.46 | -42.89 | -48.36 | -47.14 | -44.98 | -43.26 | -42.3 |
Nettoergebnis 1 | -41.24 | -45.56 | -60.67 | -60.52 | -51.12 | -41.82 | -59.16 | -57.4 | -46.24 | -43.01 | -48.71 | -47.28 | -45 | -43.39 | -43.12 |
Nettomarge | -108.67% | -108.44% | -126.06% | -107.85% | -89.2% | -77.1% | -98.3% | -90.05% | -69.08% | -60.15% | -68.82% | -63.96% | -58.18% | -51.99% | -51.57% |
Gewinn pro Aktie 2 | -0.8400 | -0.9100 | -1.130 | -1.080 | -0.9100 | -0.7400 | -1.040 | -1.010 | -0.8100 | -0.7500 | -0.8192 | -0.7764 | -0.7363 | -0.6150 | -0.7400 |
Dividende pro Aktie | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Datum der Veröffentlichung | 22.11.21 | 04.02.22 | 05.05.22 | 05.08.22 | 18.11.22 | 03.02.23 | 05.05.23 | 04.08.23 | 17.11.23 | 02.02.24 | - | - | - | - | - |
Bilanzanalyse
Steuerjahr: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Nettoschuld 1 | - | - | - | - | - | - | - | - |
Nettoliquidität 1 | 130 | 285 | 464 | 379 | 286 | 174 | 139 | 118 |
Verschuldungsgrad (Verbindlichkeiten/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | -103 | -152 | -139 | -226 | -170 | -105 | -93.4 | -73.9 |
ROE (Nettogewinn/Eigenkapital) | -89.1% | -57.3% | -33.2% | -31.8% | -29% | -33.7% | -37.5% | -40.2% |
ROA (Nettogewinn/Gesamtvermögen) | -51.4% | -47.8% | -27.6% | -26.2% | -23.5% | -26.8% | -29.2% | -27.2% |
Aktiva 1 | 209.3 | 292.9 | 550.5 | 831.7 | 868.9 | 672.5 | 534.1 | 401.9 |
Buchwert je Aktie 2 | 5.550 | 7.460 | 11.70 | 14.00 | 10.80 | 8.800 | 7.610 | 6.120 |
Cash Flow pro Aktie 2 | -3.200 | -3.630 | -2.330 | -2.310 | -2.510 | -1.480 | -1.270 | -0.8600 |
Capex 1 | 14.8 | 9.87 | 27.1 | 102 | 27.8 | 15 | 26 | 22.9 |
Capex / Umsatz | 27.13% | 10.95% | 20.45% | 50.04% | 11.33% | 5.12% | 7.3% | 5.41% |
Datum der Veröffentlichung | 11.12.19 | 23.11.20 | 22.11.21 | 18.11.22 | 17.11.23 | - | - | - |
Gewinn pro Aktie & Dividende
Historische Entwicklung KGV
Entwicklung Unternehmenswert / EBITDA
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-6.92% | 1.99 Mrd. | |
+0.44% | 90.27 Mrd. | |
+9.61% | 44.05 Mrd. | |
-16.67% | 31.45 Mrd. | |
+44.99% | 23.35 Mrd. | |
-9.42% | 16.72 Mrd. | |
-25.92% | 15.09 Mrd. | |
-9.27% | 12.82 Mrd. | |
-7.57% | 11.95 Mrd. | |
+0.07% | 8.71 Mrd. |
- Börse
- Aktien
- Aktie Twist Bioscience Corporation - Nasdaq
- Finanzen Twist Bioscience Corporation